Global Genome Engineering Market 2016-2020

  • ID: 3920541
  • Report
  • Region: Global
  • 69 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • GenScript
  • Horizon Discovery
  • Lonza
  • New England Biolabs
  • Sangamo BioSciences
  • Sigma-Aldrich
  • MORE
About Genetic Engineering

Genetic engineering is an advanced technology that modifies chromosomal DNA of animals and plants using molecular scissors (such as restriction enzyme that cut DNA into pieces). Genome engineering is now in the forefront of healthcare gaining traction with its use to fight diseases such as cancer, HIV, Malaria, sickle cell diseases.

The analysts forecast the global genome engineering market to grow at a CAGR of 12.25% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global genome engineering market for 2016-2020. To calculate the market size, the report considers the revenue generated from the clustered regularly interspaced short palindromic repeats technology.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Genome Engineering Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GenScript
- Horizon Discovery
- Integrated DNA Technologies

Other prominent vendors
- Lonza
- New England Biolabs
- Sangamo BioSciences
- Sigma-Aldrich
- Thermo Fisher Scientific
- Transposagen Biopharmaceuticals

Market drivers
- Improved specificity of CRISPR technology

Market challenges
- Stringent regulatory policies

Market trends
- Increased development of synthetic biology

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • GenScript
  • Horizon Discovery
  • Lonza
  • New England Biolabs
  • Sangamo BioSciences
  • Sigma-Aldrich
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by technology
  • Market overview
  • CRISPR
  • TALEN
  • ZFN
  • Other technologies
PART 07: Geographical segmentation
  • Genome engineering market in Americas
  • Genome engineering market in EMEA
  • Genome engineering market in APAC
PART 08: Market drivers
  • Potential opportunities in orphan diseases and oncology
  • Improved specificity of CRISPR technology
  • Increased focus on human genomics
PART 09: Impact of drivers

PART 10: Market challenges
  • Ethical issues and adverse public perception
  • Stringent regulatory policies
  • Limited skilled technological specialist
PART 11: Impact of drivers and challenges

PART 12: Market trends
  • Advances in personalized medicine
  • Increasing partnerships between CROs and pharma companies on validation studies
  • Increased development of synthetic biology
PART 13: Vendor landscape
  • Competitive scenario
PART 14: Key vendor analysis
  • Geographic presence - key vendor analysis
  • GenScript
  • Horizon Discovery Group
  • Integrated DNA Technologies
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global genome engineering market 2015-2020 ($ billions)
Exhibit 03: Global genome engineering market diversification
Exhibit 04: Five forces analysis
Exhibit 05: Global genome engineering market by technology 2015-2020
Exhibit 06: Market strategy analysis of CRISPR technology
Exhibit 07: Market dynamics of CRISPR technology
Exhibit 08: Impact assessment of key trends of CRISPR technology market
Exhibit 09: Market prediction of global genome engineering market: Major vendors and major countries
Exhibit 10: Market dynamics of TALEN technology
Exhibit 11: Impact assessment of key trends of TALEN technology market
Exhibit 12: Market dynamics of ZFN technology
Exhibit 13: Impact assessment of key trends of ZFN technology market
Exhibit 14: Drivers and challenges of antisense technology market
Exhibit 15: Drivers and challenges of mega nuclease technology market
Exhibit 16: Global genome engineering market by geography
Exhibit 17: Genome engineering market in the Americas 2015-2020 ($ billions)
Exhibit 18: Market overview of genome engineering in Americas
Exhibit 19: Genome engineering market in EMEA 2015-2020 ($ millions)
Exhibit 20: Market overview of genome engineering in EMEA
Exhibit 21: Genome engineering market in APAC 2015-2020 ($ millions)
Exhibit 22: Market overview of genome engineering in APAC
Exhibit 23: Impact of drivers
Exhibit 24: Market impact of regulatory policies in different regions
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Competitive structure analysis of global genome engineering market 2015
Exhibit 27: Market penetration of various genetic engineering tools manufacturers (2015)
Exhibit 28: Success strategies for companies in global genome engineering market
Exhibit 29: Regional analysis of key vendors
Exhibit 30: GenScript USA: Profile
Exhibit 31: GenScript: Strength analysis
Exhibit 32: GenScripts: Growth strategy matrix
Exhibit 33: Horizon Discovery Group: Profile
Exhibit 34: Horizon Discovery Group: Strength analysis
Exhibit 35: Horizon Discovery Group: Growth strategy matrix
Exhibit 36: Horizon Discovery Group: Opportunity analysis
Exhibit 37: Integrated DNA technologies profile
Exhibit 38: Integrated DNA technologies: Strength analysis
Exhibit 39: Integrated DNA technologies: Growth strategy matrix
Exhibit 40: Integrated DNA technologies: Opportunity analysis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • GenScript
  • Horizon Discovery
  • Lonza
  • New England Biolabs
  • Sangamo BioSciences
  • Sigma-Aldrich
  • MORE
New Report Released: - Global Genome Engineering Market 2016-2020

The author of the report recognizes the following companies as the key players in the global genome engineering market: GenScript, Horizon Discovery, and Integrated DNA Technologies.

Other Prominent Vendors in the market are: Lonza, New England Biolabs, Sangamo BioSciences, Sigma-Aldrich, Thermo Fisher Scientific, and Transposagen Biopharmaceuticals.

Commenting on the report, an analyst from the research team said: “Increased development of synthetic biology will be a key trend for market growth. Synthetic biology is a process of redesigning and constructing new biological parts, that do not exist in the natural world. The increasing R&D expenditure in pharma and biotech companies, increased government funding, and advanced technology in genome engineering, have increased the demand for Synthetic biology The production of synthetic genes is nowadays possible through genome engineering techniques (CRISPR, ZNF, TALEN).”

According to the report, increased focus on human genomics will be a key driver for market growth. Human genome project has vast potential applications of genetic engineering, and it requires effort to understand and map the DNA of human's when compared to other organisms. To understand and sequence the human genome, the Department of Energy and the National Human Genome Research Institute in the US and their partners in the International Human Genome Sequencing Consortium initiated the Human Genome Project in 1990. The project sequenced only the euchromatic regions that constitute 90% of the genome including 20,000-25,000 genes. The successful completion of the project in 2003 led to improvements in DNA technology.

Further, the report states that stringent regulatory policies will be a challenge for the market. The stringent policies of genetic engineering have restricted the market worldwide. Though the regulatory rules vary from country to country, they all have strict regulatory policies when it comes to release of any genetically modified organism. Europe does not have single regulatory policies but it has a cluster of policies at international, community, member state, and local levels. In Europe, the usage of gene therapy in human embryo is restricted.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- GenScript
- Horizon Discovery
- Integrated DNA Technologies
- Lonza
- New England Biolabs
- Sangamo BioSciences
- Sigma-Aldrich
- Thermo Fisher Scientific
- and Transposagen Biopharmaceuticals
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll